OpenVSafe by OpenVAERS
Search V-safe

WU6-89039-41552

2 vaccinations 3 coded responses 24 check-ins 3 free-text entries 2 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
331 / FL
Registered
2021-04-08
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2260168 (opens in a new window) high 10 / 11 1 1 of 4 VAERS symptoms same dose (2) FL matches 2021-04-29 / 2021-04-29 / 2022-05-02
received the same day as the last call
 case 614302

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-04-08
    Registered in v-safe
  2. 2021-04-08
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-08
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-04-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-04-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-15
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-04-22
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-29
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-29
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-04-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-05-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-05-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-05-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-05-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-05-06
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-05-13
    Survey response — day 14, dose 2
    MedDRA: Headache, Pyrexia — Feeling: Good · Be unable to do your normal daily activities
    Free text: 24 hour fever/headache on 05/08
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-05-22
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-27
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-06-03
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-06-10
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-07-29
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-10-28
    Survey response — 6 months, dose 2
    MedDRA: Postpartum state, Thyroiditis subacute — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Subacute thyroiditis started in September. Important to note I received vaccine within 1 month postpartum.
    MedDRA releases: 2024-11 · check-in free text available
  27. 2021-10-28
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  28. 2021-10-29
  29. 2022-04-29
    Survey response — 12 months, dose 2
    MedDRA: Heart rate increased, Thyroiditis subacute — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: I experienced subacute thyroiditis in Sept. Progressively got worse without medication. Heart rate reached 147 on October 31st. Was put on propanol and thyroid medication until January. Thyroid has been stable since and continue to monitor.
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-04-29
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  31. 2022-05-02
    Call successful
    Completed over the phone

Vaccinations

DoseDateManufacturerCo-administered
12021-04-08Pfizer-BioNTech
22021-04-29Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-10-28 Successful Completed over the phone
2022-04-29 Successful
2022-05-02
 Completed over the phone

Free text

Release 8 — day 14, dose 2

2021-05-13

Symptoms: 24 hour fever/headache on 05/08

Release 10 — 6 months, dose 2

2021-10-28

Symptoms: Subacute thyroiditis started in September. Important to note I received vaccine within 1 month postpartum.

Release 11 — 12 months, dose 2

2022-04-29

Symptoms: I experienced subacute thyroiditis in Sept. Progressively got worse without medication. Heart rate reached 147 on October 31st. Was put on propanol and thyroid medication until January. Thyroid has been stable since and continue to monitor.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHeadache ✓ ✓ ✓
SDHeart rate increased · · ✓
SDPostpartum state · · ✓
SDPyrexia ✓ ✓ ✓
SDThyroiditis subacute · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…